AdvaMed issues pandemic compliance guidance for med-tech
By 
Jaclyn Jaeger2020-05-15T15:26:00
The Advanced Medical Technology Association has released new compliance guidance for medical-technology companies to guide them in mitigating compliance and corruption risks as they help healthcare providers fight coronavirus.
Related articles
-
ArticleNavigating the return of employees to the workplace
Bringing employees back from working from home means reacting to ever-changing recommendations from health experts as well as the mandates of state and local officials.
-
ArticleDo we have to give up our privacy to be safe from coronavirus?
How much of your privacy rights and civil liberties are you willing to give up in the fight against the coronavirus pandemic? Our collective answer might determine how successful we are in the next phase of this fight.
-
ArticleSo your company’s CEO has coronavirus. Does the world have to know?
As infections stemming from the coronavirus pandemic continue to mount around the world, publicly traded companies face questions about when and where to disclose that their CEO or other key executives have contracted the virus.
More from Risk Management
-
News BriefFederal Reserve Board drops reputational risk from exams, aligning with OCC and FDIC shift
Bank examiners at the Federal Reserve Board will no longer assess reputational risk during examinations, a concession to the banking industry already underway with two other U.S. regulators.
-
News BriefCOSO’s draft corporate governance framework provides roadmap to compliant business practices
Corporate governance is, all too often, handed down from generation to generation. Like a well-worn jacket, it works great—until it doesn’t. Typically, it is a crisis that forces companies to reassess their corporate governance framework, as gaps are filled and poor policies rewritten. But it doesn’t have to be that ...
-
News BriefInvestment scammers, other fraudsters scored billions from consumers in 2024, FTC reports
The public reported a 25 percent increase in losses–totaling more than $12.5 billion in 2024–to investment scams, tech rip-offs, and general fraud, according to an analysis by the Federal Trade Commission.